Zileuton

FDA Approved: * March 17, 2017
Pharm Company: * PACK PHARMS LLC
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zileuton Overview

Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation, used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names ZYFLO and ZYFLO CR. The original immediate-release formulation, ZYFLO, is taken four times per day. The extended-release formulation, ZYFLO CR, is take...

Read more Zileuton Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Zileuton

Recent Zileuton Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Zileuton
  • Tablet: 300mg, 600mg
  • Tablet, Extended Release: 600mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zileuton: (3 results)

Sorted by National Drug Code
  • 24486-902 Zileuton 600 mg Oral Tablet, Extended Release by Aristos Phamaceuticals, Inc.
  • 64980-206 Zileuton 600 mg Oral Tablet, Extended Release by Rising Pharmaceuticals, Inc.
  • 66993-485 Zileuton 600 mg Oral Tablet, Extended Release by Prasco, LLC

Other drugs which contain Zileuton or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA